Member Info for TrickyEFC

I believe Mr Potts was the other private individual.

He was Happy to be paid off with shares which so far he still currently holds and has so far been rewarded for his support of the company with a handsome return on his investment. Do you think he is in any rush to sell?

💪😁

From early in 2024 just before the pivot from GPL to Solvonis.

New loan facility

The changes to the board follow the provision of a £100,000 working capital loan facility to the Company by Mr Nelson and another private individual (the "Loan Facility"). The Loan Facility is intended to be drawn down in full against expenses incurred by the Company as they arise, and it attracts an interest rate of 10% per month. Although the loan is technically repayable on demand, together with accumulated interest, it is mutually agreed in writing to convert all or any part of the outstanding balance of the Loan (including interest) in the form of new ordinary shares issued by the Company at a price and time agreed between the lenders and the Company

He is currently sitting over 100% up on his investment.

Sorry he's a consultant to Solvonis.

June 24 rns

Nicholas Nelson (Non-Executive Chairman) has subscribed for 25,000,000 Placing Shares. William Potts, a consultant to the Company, has subscribed for 400,000,000 Placing Shares, in each case at the Issue Price.

William Potts jumped in on the raise last June and has held since. That is all I know of Mr Potts.

Revised over 0.6p this week.

It can't stay under £36 million

Dv Was trying to stay awake in the early hours for the UFC.

Once again crashed after the 1st match of main card.

Yep what Chas said over 0.5p this week.

As for what to expect in 2025, PwC’s analyst team has said it expects to see sustained activity for transactions between $5 billion and $15 billion, noting that incoming new leaders at the U.S. Department of Justice and the FTC could assuage some concerns that prevented bigger deals from taking shape over the past few years.

On that front, President-elect Donald Trump recently nominated FTC Commissioner Andrew Ferguson to head up the U.S. antitrust agency, signaling the end of the tenacious tenure of outgoing Chair Lina Khan.

Ferguson has been heralded as an overall net positive for biopharma dealmaking, with industry watchers speculating he will employ a lighter touch than Khan did. Khan, for her part, made a name for herself taking a hard stance against drugmakers and launching campaigns to further scrutinize healthcare M&A, embrace “march-in” rights and challenge patents her agency claimed were improperly listed in the FDA’s Orange Book.

Looking past the regulatory landscape, large-cap biopharmas are likely to display a sustained interested in M&A in the coming months, though the focus seems to remain fixed on small to medium and early- to midstage deals, analysts at Leerink Partners wrote in their October report.

Plenty of volume for Pamlico Shoals to offload 550mil which would then require declaring dropping under 3%.

nothing so far.

This may very very well go off big time this week.

I meant to mention Nick nelson and spread ex is that just a coincidence or has mr nelson lent his shares out or something???

8 large holders currently have 40% of the share capital.

Approx 38% of the shares are held by Awakn long term holders (this is assuming that not many have been selling, after years of funding Awakn why would they exit now).

That leaves about 1.3billion shares unaccounted for.

if we have 80 PI's here with an average holding of 16 million then the free float would be pretty much zero.

Pamlico Shoals Targeted Opportunities Fund LP 730,306,344

William Potts 610,461,538

Nicholas Nelson 205.961,538

SpreadEx Ltd. 205,961,538

Oberon Investments Ltd. (GB Investment Management) 189,613,635

Stuart Sharpless 144,879,933 increased to 196,351,963

Steven Myers 117,500,000

Paul Levinson 75,000,000

total 2,331,156,556

Given that phase 3 is fully funded for Solvonis going off this research tool we need to increase approx 100times for fair value.

Value at start of Phase 3

$1,121M

Probability of FDA approval: 56%

Investment required for approval: $405M

16:45:51 0.222 21,900,928 Unknown* 48.62k

having kept close eye on trading i am pretty sure that this is the biggest value single buy trade since the rebrand last June.

Given that it happened on the same week that the Singer note has been made available to the big boys ya never know Rodney this time next week we could all be 100% richer next week for starters.

Need to switch off till Monday.

It's bringing back vibes of waiting for Santa as a kid 😂😂😂

Top top top discourse.

Liked the questions posed by joli and loved the response more so.

The most mind blowing fact for me is that talk of a share price north of 8p is well within the realms of reality.

ps the posters on this board make it best board on lse.

Nano cap thank you for the information.

Anyone else starting to think that this company is rather blessed.

Think it was Chas emailed in and they responded saying they would sort this out re share issue.

Hi Lord. Wednesday was able to get in At the 18s

Monday if you not early could be looking at 24.

I believe general consensus would be that 24 would still be a lovely entry point.

Remember a 200% from rise from 0.215p would see us hit a market cap of just £35million nuff said.

🆙⬆️🆙

And pushed the volume over 200million.

What a time to have to deal with a weekend 😂😂😂😂